<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7692906" created="28/02/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7692906</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term id="T1" lex="HIV-1_latency_reactivation" sem="Other"><term id="T2" lex="HIV-1" sem="Virus">HIV-1</term> latency reactivation</term> by <term id="T3" lex="dehydroepiandrosterone" sem="Lipid">dehydroepiandrosterone</term> (<term id="T4" lex="DHEA" sem="Lipid">DHEA</term>) and an <term id="A1" sem="Lipid">analog of <term id="T5" lex="DHEA" sem="Lipid">DHEA</term></term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Negative_regulation"/>
<theme idref="T1"/>
<cause idref="T4"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> HIV-1 latency reactivation <linkCause>by</linkCause> dehydroepiandrosterone (DHEA) and an analog of DHEA.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="T1"/>
<cause idref="A1"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> HIV-1 latency reactivation <linkCause>by</linkCause> dehydroepiandrosterone (DHEA) and an analog of DHEA.</clue>
<comment>TPS: A1</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The initial infection with <term id="T6" lex="human_immunodeficiency_virus_type_1" sem="Virus">human immunodeficiency virus type 1</term> (<term id="T7" lex="HIV-1" sem="Virus">HIV-1</term>) in most individuals usually results in the establishment of a latent or <term id="T8" lex="chronic_infection" sem="Other">chronic infection</term> before eventual progression toward <term id="T9" lex="acquired_immunodeficiency_syndrome" sem="Other">acquired immunodeficiency syndrome</term>.</sentence>
<event KT="Other" id="E3">
<type class="Initiation_of_viral_infection"/>
<theme idref="T7"/>
<clue>The initial <clueType>infection</clueType> <linkTheme>with</linkTheme> human immunodeficiency virus type 1 (HIV-1) in most individuals usually results in the establishment of a latent or chronic infection before eventual progression toward acquired immunodeficiency syndrome.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="E3"/>
<clue>The initial infection with human immunodeficiency virus type 1 (HIV-1) <clueLoc>in most individuals</clueLoc> usually <clueType>results in</clueType> the establishment of a latent or chronic infection <clueTime>before eventual progression toward acquired immunodeficiency syndrome.</clueTime></clue>
</event>
<event KT="Other" id="E50">
<type class="Viral_life_cycle"/>
<theme idref="T7"/>
<clue>The initial infection with human immunodeficiency virus type 1 (HIV-1) in most individuals usually results in the establishment of a latent or <clueType>chronic infection</clueType> before eventual progression toward acquired immunodeficiency syndrome.</clue>
</event>
<event KT="Fact" id="E150">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<cause idref="E3"/>
<clue>The initial infection with human immunodeficiency virus type 1 (HIV-1) in most individuals usually results in the establishment of a latent or chronic infection before eventual <clueType>progression</clueType> <linkTheme>toward</linkTheme> acquired immunodeficiency syndrome.</clue>
</event>
<sentence id="S3"><term id="T10" lex="HIV-1" sem="Virus">HIV-1</term> can also establish a latent or persistent infection in some <term id="T11" lex="T_cell_line" sem="Cell_cultured">T cell lines</term> that show minimal <term id="T12" lex="constitutive_virus_expression" sem="Other">constitutive virus expression</term>.</sentence>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T10"/>
<clue>HIV-1 can also establish a latent or persistent infection <clueLoc>in some T cell lines</clueLoc> that show minimal constitutive virus <clueType>expression</clueType>.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Viral_life_cycle"/>
<theme idref="T10"/>
<clue>HIV-1 can also establish a latent or <clueType>persistent infection</clueType> <clueLoc>in some T cell lines</clueLoc> that show minimal constitutive virus expression.</clue>
</event>
<sentence id="S4">However, activation of the <term id="T13" lex="T_cell_line" sem="Cell_cultured">T cell lines</term> leading to enhanced <term id="T14" lex="HIV-1" sem="Virus">HIV-1</term> replication can be induced by <term id="T15" lex="antigen" sem="Protein_family_or_group">antigens</term>, <term id="T16" lex="mitogen" sem="Other">mitogens</term>, and <term id="T17" lex="cytokine" sem="Protein_family_or_group">cytokines</term> (<term id="T18" lex="tumor_necrosis_factor_alpha" sem="Protein_family_or_group">tumor necrosis factor alpha</term> [<term id="T19" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>], <term id="T20" lex="interleukin_1" sem="Protein_molecule">interleukin 1</term>, and <term id="T21" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term>).</sentence>
<event KT="Other" id="E7">
<type class="Physiological_process"/>
<theme idref="T13"/>
<clue>However, <clueType>activation</clueType> <linkTheme>of</linkTheme> the T cell lines leading to enhanced HIV-1 replication can be induced by antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Other" id="E8">
<type class="Viral_life_cycle"/>
<theme idref="T14"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 <clueType>replication</clueType> can be induced by antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<clue>However, activation of the T cell lines leading to <clueType>enhanced</clueType> HIV-1 replication can be induced by antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E7"/>
<clue>However, activation of the T cell lines <clueType>leading to</clueType> enhanced HIV-1 replication can be induced by antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T15"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T16"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E51">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T17"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and cytokines (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E13">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T19"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and <corefCause>cytokines</corefCause> (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E14">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T20"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and <corefCause>cytokines</corefCause> (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<event KT="Fact" id="E15">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T21"/>
<clue>However, activation of the T cell lines leading to enhanced HIV-1 replication can be <clueType>induced</clueType> <linkCause>by</linkCause> antigens, mitogens, and <corefCause>cytokines</corefCause> (tumor necrosis factor alpha [TNF-alpha], interleukin 1, and interleukin-2).</clue>
</event>
<sentence id="S5">Various <term id="A2" sem="Protein_molecule">gene products from</term> other viruses (<term id="T22" lex="HTLV-1" sem="Virus">HTLV-1</term>, <term id="T23" lex="HSV" sem="Virus">HSV</term>, <term id="T24" lex="EBV" sem="Virus">EBV</term>, <term id="T25" lex="CMV" sem="Virus">CMV</term>, <term id="T26" lex="HBV" sem="Virus">HBV</term>, and <term id="T27" lex="HHV-6" sem="Virus">HHV-6</term>) can also enhance <term id="T28" lex="HIV-1_long_terminal_repeat_(LTR)-driven_reporter_gene_activity" sem="Other"><term id="T29" lex="HIV-1" sem="Virus">HIV-1</term> <term id="T30" lex="long_terminal_repeat" sem="DNA_domain_or_region">long terminal repeat</term> (<term id="T31" lex="LTR" sem="DNA_domain_or_region">LTR</term>)-driven <term id="T32" lex="reporter_gene" sem="DNA_family_or_group">reporter gene</term> activity</term>.</sentence>
<event KT="Fact" id="E22">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T22"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<event KT="Fact" id="E23">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T23"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<event KT="Fact" id="E24">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T24"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<event KT="Fact" id="E25">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T25"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<event KT="Fact" id="E26">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T26"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<event KT="Fact" id="E27">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<cause idref="A2" idref1="T27"/>
<clue>Various gene products from other viruses (HTLV-1, HSV, EBV, CMV, HBV, and HHV-6) can also <clueType>enhance</clueType> HIV-1 long terminal repeat (LTR)-driven reporter gene activity.</clue>
</event>
<sentence id="S6">On the basis of these observations, it has been proposed that reactivation of latent <term id="T33" lex="HIV-1" sem="Virus">HIV-1</term> harbored in <term id="T34" lex="chronically_infected_T_lymphocyte" sem="Cell_natural">chronically infected T lymphocytes</term>, <term id="T35" lex="monocyte" sem="Cell_natural">monocytes</term>, or <term id="T36" lex="macrophage" sem="Cell_natural">macrophages</term> plays an important role in the pathogenesis of <term id="T37" lex="AIDS" sem="Other">AIDS</term>.</sentence>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<clue>On the basis of these observations, it has been proposed that <clueType>reactivation</clueType> <linkTheme>of</linkTheme> latent HIV-1 harbored <clueLoc>in chronically infected T lymphocytes, monocytes, or macrophages</clueLoc> plays an important role in the pathogenesis of AIDS.</clue>
</event>
<event KT="Other" id="E29">
<type/>
<theme idref="T37"/>
<clue>On the basis of these observations, it has been proposed that reactivation of latent HIV-1 harbored in chronically infected T lymphocytes, monocytes, or macrophages plays an important role in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> AIDS.</clue>
<comment>SOO</comment></event>
<event KT="Analysis" Source="Other" id="E30" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E28"/>
<theme idref="E29"/>
<clue>On the basis of these observations, it <clueSource>has been</clueSource> <clueKT>proposed</clueKT> that reactivation of latent HIV-1 harbored in chronically infected T lymphocytes, monocytes, or macrophages <clueType>plays</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> the pathogenesis of AIDS.</clue>
</event>
<sentence id="S7">So far, there are no <term id="A4" sem="Other">drugs</term> or <term id="A5" sem="Other">therapy</term> available that can provide protection against <term id="T38" lex="HIV-1_latency_reactivation" sem="Other"><term id="T39" lex="HIV-1" sem="Virus">HIV-1</term> latency reactivation</term>.</sentence>
<event KT="Other" id="E52">
<type class="Viral_life_cycle"/>
<theme idref="T39"/>
<clue>So far, there are no drugs or therapy available that can provide protection against HIV-1 latency <clueType>reactivation</clueType>.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E31">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="A4"/>
<clue>So far, there are <cluePolarity>no</cluePolarity> drugs or therapy available that can provide <clueType>protection</clueType> <linkTheme>against</linkTheme> HIV-1 latency reactivation.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E32">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="A5"/>
<clue>So far, there are <cluePolarity>no</cluePolarity> drugs or therapy available that can provide <clueType>protection</clueType> <linkTheme>against</linkTheme> HIV-1 latency reactivation.</clue>
</event>
<sentence id="S8"><term id="T40" lex="ACH-2" sem="Cell_cultured">ACH-2</term>, derived from a <term id="T41" lex="human_T_cell_line" sem="Cell_cultured">human T cell line</term> (<term id="T42" lex="CEM" sem="Cell_cultured">CEM</term>), is chronically infected with <term id="T43" lex="HIV-1" sem="Virus">HIV-1</term>, with low levels of <term id="T44" lex="constitutive_virus_expression" sem="Other">constitutive virus expression</term>.</sentence>
<event id="E53">
<type class="Viral_life_cycle"/>
<theme idref="T43"/>
<theme idref="T40"/>
<clue>ACH-2, derived from a human T cell line (CEM), is <clueType>chronically infected</clueType> <linkTheme>with</linkTheme> HIV-1, with low levels of constitutive virus expression.</clue>
</event>
<event Manner="Low" id="E33">
<type class="Gene_expression"/>
<theme idref="T43"/>
<clue><clueLoc>ACH-2</clueLoc>, derived from a human T cell line (CEM), is chronically infected with HIV-1, with <clueManner>low levels</clueManner> of constitutive virus <clueType>expression</clueType>.</clue>
</event>
<sentence id="S9"><term id="T45" lex="ACH-2" sem="Cell_cultured">ACH-2</term> can be converted to <term id="A6" sem="Other">productive infection</term> by stimulation of the cells with <term id="T46" lex="12-O-tetradecanoylphorbol-13-acetate" sem="Organic_compound_other">12-O-tetradecanoylphorbol-13-acetate</term> (<term id="T47" lex="TPA" sem="Organic_compound_other">TPA</term>), <term id="T48" lex="mitogen" sem="Organic_compound_other">mitogen</term> or <term id="T49" lex="cytokine" sem="Protein_family_or_group">cytokines</term> (<term id="T50" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>), or infection with <term id="T51" lex="HSV" sem="Virus">HSV</term>.</sentence>
<event KT="Other" id="E34">
<type class="Initiation_of_viral_infection"/>
<theme idref="T51"/>
<theme idref="T45"/>
<clue>ACH-2 can be converted to productive infection by stimulation of the cells with 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or <clueType>infection</clueType> <linkTheme>with</linkTheme> HSV.</clue>
</event>
<event KT="Other" id="E54">
<type class="Physiological_process"/>
<theme idref="T45"/>
<cause idref="T47"/>
<clue>ACH-2 can be converted to productive infection by <clueType>stimulation</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event KT="Other" id="E55">
<type class="Physiological_process"/>
<theme idref="T45"/>
<cause idref="T48"/>
<clue>ACH-2 can be converted to productive infection by <clueType>stimulation</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event KT="Other" id="E56">
<type class="Physiological_process"/>
<theme idref="T45"/>
<cause idref="T50"/>
<clue>ACH-2 can be converted to productive infection by <clueType>stimulation</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event KT="Other" id="E57">
<type class="Physiological_process"/>
<theme idref="T45"/>
<cause idref="E34"/>
<clue>ACH-2 can be converted to productive infection by <clueType>stimulation</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event CL="L2" KT="Analysis" id="E35">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="E54"/>
<clue>ACH-2 <clueKT><clueCL>can</clueCL></clueKT> be <clueType>converted to</clueType> productive infection by stimulation of the cells <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event CL="L2" KT="Analysis" id="E36">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="E55"/>
<clue>ACH-2 <clueKT><clueCL>can</clueCL></clueKT> be <clueType>converted to</clueType> productive infection by stimulation of the cells <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event CL="L2" KT="Analysis" id="E37">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="E56"/>
<clue>ACH-2 <clueKT><clueCL>can</clueCL></clueKT> be <clueType>converted to</clueType> productive infection by stimulation of the cells <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<event CL="L2" KT="Analysis" id="E38">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="E57"/>
<clue>ACH-2 <clueKT><clueCL>can</clueCL></clueKT> be <clueType>converted to</clueType> productive infection by stimulation of the cells <linkCause>with</linkCause> 12-O-tetradecanoylphorbol-13-acetate (TPA), mitogen or cytokines (TNF-alpha), or infection with HSV.</clue>
</event>
<sentence id="S10">Therefore the <term id="T52" lex="ACH-2" sem="Cell_cultured">ACH-2</term> cell line is a good candidate for studying the effects of <term id="A7" sem="Other">drugs</term> on <term id="T53" lex="HIV-1" sem="Virus">HIV-1</term> activation.</sentence>
<event KT="Other" id="E39">
<type class="Positive_regulation"/>
<theme idref="T53"/>
<clue>Therefore the ACH-2 cell line is a good candidate for studying the effects of drugs on HIV-1 <clueType>activation</clueType>.</clue>
</event>
<event KT="Investigation" id="E40" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E39"/>
<cause idref="A7"/>
<clue>Therefore the <clueLoc>ACH-2 cell line</clueLoc> is a good candidate for <clueKT>studying</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> drugs <linkTheme>on</linkTheme> HIV-1 activation.</clue>
</event>
<sentence id="S11">Previously, we have reported that <term id="T54" lex="DHEA" sem="Lipid">DHEA</term> and synthetic <term id="A8" sem="Lipid">analogs of <term id="T55" lex="DHEA" sem="Lipid">DHEA</term></term> can be modest inhibitors of <term id="T56" lex="HIV-1_IIIB_replication" sem="Other"><term id="T57" lex="HIV-1" sem="Virus">HIV-1</term> IIIB replication</term> in <term id="T58" lex="phytohemagglutinin-stimulated_peripheral_blood_lymphocyte_culture" sem="Cell_cultured"><term id="A16" sem="Protein_molecule">phytohemagglutinin</term>-stimulated <term id="A17" sem="Cell_natural">peripheral blood lymphocyte</term> cultures</term>.</sentence>
<event KT="Other" id="E58">
<type class="Viral_life_cycle"/>
<theme idref="T57"/>
<clue>Previously, we have reported that DHEA and synthetic analogs of DHEA can be modest inhibitors of HIV-1 IIIB <clueType>replication</clueType> in phytohemagglutinin-stimulated peripheral blood lymphocyte cultures.</clue>
</event>
<event KT="Other" id="E59">
<type class="Physiological_process"/>
<theme idref="A17"/>
<cause idref="A16"/>
<clue>Previously, we have reported that DHEA and synthetic analogs of DHEA can be modest inhibitors of HIV-1 IIIB replication in phytohemagglutinin-<clueType>stimulated</clueType> peripheral blood lymphocyte cultures.</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E41">
<type class="Negative_regulation"/>
<theme idref="E58"/>
<cause idref="T54"/>
<clue><clueSource>Previously</clueSource>, we have <clueKT>reported</clueKT> that DHEA and synthetic analogs of DHEA <clueCL>can</clueCL> be modest <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> HIV-1 IIIB replication <clueLoc>in phytohemagglutinin-stimulated peripheral blood lymphocyte cultures.</clueLoc></clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E42">
<type class="Negative_regulation"/>
<theme idref="E58"/>
<cause idref="A8"/>
<clue><clueSource>Previously</clueSource>, we have <clueKT>reported</clueKT> that DHEA and synthetic analogs of DHEA <clueCL>can</clueCL> be modest <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> HIV-1 IIIB replication <clueLoc>in phytohemagglutinin-stimulated peripheral blood lymphocyte cultures.</clueLoc></clue>
<comment>TPS: A8</comment></event>
<sentence id="S12">(ABSTRACT TRUNCATED AT 250 WORDS)</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
